Indivior Pharmaceuticals, Inc. - 8-K Filing

Indivior Pharmaceuticals and Supernus announce merger agreement dated August 1, 2026. (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $INDV

Read the full article at SEC EDGAR

More Regulatory news